We further hypothesized that these Y-T2D plasma–derived small ECVs would alter cellular function by reducing eNOS signaling, impairing NO production, and promoting the expression of inflammatory cytokines. This evidence concerns the gene NOS3 and type 2 diabetes mellitus.